把三张表、经营指标、SEC / 巨潮 / 港交所原始财报、业绩材料和电话会放到同一条可核验时间线上。 披露事实、结构化补位值与派生指标分开标注，缺失逐字稿不会用摘要或模型生成内容补齐。
单季、累计、年度和资产负债表时点分开保存；每个数值都保留单位、申报日、表单、XBRL 概念或原始中文字段。
美股链接 SEC 法定申报和发行人 IR，A 股链接巨潮原始 PDF，港股链接港交所披露易原始年报与中报。分部、订单、产能和客户集中度只在有可核验披露时展示。
官方电话会入口与已授权逐字稿分开。没有合法取得的全文时只显示材料可用性，不生成或拼接虚假的逐字稿。
三张表会执行资产负债、毛利润、税前利润等勾稽检查；超出容差的记录保留原值并标记警告， 不会为了让公式“对上”而修改公司披露。
| 2026-06-30 |
| 3/3 |
| $42.21M |
| -$7.65M |
| — |
| 35.5% |
| -28.5% |
| 98 |
| 尚无授权文本 |
| BHE BENCHMARK ELECTRONICS INC | 2026-06-30 | 3/3 | $777.5M | $19.88M | $52.92M | 10.1% | 3.9% | 104 | 尚无授权文本 |
| CBIO CRESCENT BIOPHARMA, INC. | 2026-06-30 | 3/3 | $0 | -$24.84M | -$28.56M | — | -4917.5% | 80 | 尚无授权文本 |
| EXP EAGLE MATERIALS INC | 2026-06-30 | 3/3 | $650.97M | $102.13M | $33.62M | 24.8% | — | 91 | 尚无授权文本 |
| FMAO FARMERS & MERCHANTS BANCORP INC | 2026-06-30 | 3/3 | — | $11.8M | $17.58M | — | — | 87 | 尚无授权文本 |
| GRC GORMAN RUPP CO | 2026-06-30 | 3/3 | — | $19.43M | — | — | — | 60 | 尚无授权文本 |
| HOOD Robinhood Markets, Inc. | 2026-06-30 | 3/3 | $1.31B | $561M | — | — | — | 76 | 尚无授权文本 |
| HZO MARINEMAX INC | 2026-06-30 | 3/3 | $611.26M | $15.36M | $130.02M | 35.7% | 6.1% | 81 | 尚无授权文本 |
| IBM INTERNATIONAL BUSINESS MACHINES CORP | 2026-06-30 | 3/3 | $17.16B | $2.17B | $7.31B | 57.7% | — | 126 | 尚无授权文本 |
| IMAX IMAX CORP | 2026-06-30 | 3/3 | $102.84M | $15.4M | $33.86M | 61.2% | 20.2% | 83 | 尚无授权文本 |
| IONS IONIS PHARMACEUTICALS INC | 2026-06-30 | 3/3 | $267.95M | -$114.65M | -$265.13M | 99.0% | -38.2% | 120 | 尚无授权文本 |
| LOAN MANHATTAN BRIDGE CAPITAL, INC | 2026-06-30 | 3/3 | $2.05M | $1.15M | — | — | 56.2% | 41 | 尚无授权文本 |
| MA Mastercard Inc | 2026-06-30 | 3/3 | $9.28B | $4.39B | $6.33B | — | 60.2% | 90 | 尚无授权文本 |
| MAIR Madison Air Solutions Corp | 2026-06-30 | 3/3 | $991.3M | $69.2M | $139.9M | 39.0% | 19.7% | 7 | 尚无授权文本 |
| MAX MediaAlpha, Inc. | 2026-06-30 | 3/3 | $316.88M | $39.44M | $40.22M | 14.3% | 6.3% | 89 | 尚无授权文本 |
| MCFT MasterCraft Boat Holdings, Inc. | 2026-06-30 | 3/3 | — | — | — | — | — | 79 | 尚无授权文本 |
| MCS MARCUS CORP | 2026-06-30 | 3/3 | $231.74M | $15.84M | $22.09M | — | 11.7% | 77 | 尚无授权文本 |
| MDGL MADRIGAL PHARMACEUTICALS, INC. | 2026-06-30 | 3/3 | $364.25M | -$57.94M | -$152.21M | — | -15.5% | 87 | 尚无授权文本 |
| MKL MARKEL GROUP INC. | 2026-06-30 | 3/3 | $4.02B | $1.17B | $353.19M | — | 38.8% | 75 | 尚无授权文本 |
| MLM MARTIN MARIETTA MATERIALS INC | 2026-06-30 | 3/3 | $1.95B | $251M | $25M | 25.4% | 19.1% | 99 | 尚无授权文本 |
| MMLP MARTIN MIDSTREAM PARTNERS L.P. | 2026-06-30 | 3/3 | $213.6M | $2.65M | -$18.59M | 49.6% | 9.0% | 68 | 尚无授权文本 |
| MOD MODINE MANUFACTURING CO | 2026-06-30 | 3/3 | $874.1M | $73.9M | -$5M | 20.8% | 8.6% | 100 | 尚无授权文本 |
| MRSH MARSH & MCLENNAN COMPANIES, INC. | 2026-06-30 | 3/3 | $7.4B | $1.27B | $701M | — | 25.6% | 84 | 尚无授权文本 |
| MTZ MASTEC INC | 2026-06-30 | 3/3 | $4.37B | $130.12M | — | — | 5.2% | 87 | 尚无授权文本 |
| MXL MAXLINEAR, INC | 2026-06-30 | 3/3 | $168.85M | $1.76M | -$7.79M | 57.8% | -2.5% | 81 | 尚无授权文本 |
| NEU NEWMARKET CORP | 2026-06-30 | 3/3 | $747.09M | $133.75M | $234.42M | 32.4% | 21.9% | 86 | 尚无授权文本 |
| NLY ANNALY CAPITAL MANAGEMENT INC | 2026-06-30 | 3/3 | — | $822.67M | — | — | — | 137 | 尚无授权文本 |
| NOC NORTHROP GRUMMAN CORP /DE/ | 2026-06-30 | 3/3 | $10.88B | $1.09B | -$845M | — | 10.1% | 86 | 尚无授权文本 |
| PHAT Phathom Pharmaceuticals, Inc. | 2026-06-30 | 3/3 | $74.27M | -$17.58M | -$17.68M | 79.7% | -5.3% | 113 | 尚无授权文本 |
| REGN REGENERON PHARMACEUTICALS, INC. | 2026-06-30 | 3/3 | $4.29B | $1.3B | — | — | 30.1% | 82 | 尚无授权文本 |
| SAMG Silvercrest Asset Management Group Inc. | 2026-06-30 | 3/3 | $30.78M | $170,000 | -$17.87M | — | 3.1% | 97 | 尚无授权文本 |
| SMHI SEACOR Marine Holdings Inc. | 2026-06-30 | 3/3 | — | $3.29M | -$40.83M | — | — | 89 | 尚无授权文本 |
| SOLS Solstice Advanced Materials Inc. | 2026-06-30 | 3/3 | $1.15B | $119M | $248M | 32.2% | — | 19 | 尚无授权文本 |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | 2026-06-30 | 3/3 | $4.14B | -$576M | — | 52.0% | -5.6% | 84 | 尚无授权文本 |
| TW Tradeweb Markets Inc. | 2026-06-30 | 3/3 | $558.95M | $181.32M | $480.01M | — | 43.9% | 78 | 尚无授权文本 |
| UNMA Unum Group | 2026-06-30 | 3/3 | $3.37B | $256.9M | $775.5M | — | — | 91 | 尚无授权文本 |
| WST WEST PHARMACEUTICAL SERVICES INC | 2026-06-30 | 3/3 | $872.3M | $154M | $128M | 37.7% | 20.5% | 77 | 尚无授权文本 |
| LMT LOCKHEED MARTIN CORP | 2026-06-28 | 3/3 | $20.06B | $1.84B | — | 12.2% | 12.4% | 93 | 尚无授权文本 |
| SFM Sprouts Farmers Market, Inc. | 2026-06-28 | 3/3 | $2.33B | $129.2M | $179.09M | 38.7% | 7.5% | 75 | 尚无授权文本 |
| WINA WINMARK CORP | 2026-06-27 | 3/3 | $21.97M | $10.39M | $22.55M | — | 62.1% | 73 | 尚无授权文本 |
| ARTW ARTS WAY MANUFACTURING CO INC | 2026-05-31 | 3/3 | $7.85M | $173,479 | -$6,644 | 25.9% | 3.6% | 62 | 尚无授权文本 |
| KMX CARMAX INC | 2026-05-31 | 3/3 | $8.01B | $185.63M | -$85.75M | 10.7% | — | 75 | 尚无授权文本 |
| PRGS PROGRESS SOFTWARE CORP /MA | 2026-05-31 | 3/3 | $253.47M | $21.07M | $172.89M | 82.3% | 17.8% | 79 | 尚无授权文本 |
| PSMT PRICESMART INC | 2026-05-31 | 3/3 | $1.48B | $39.69M | $48.14M | 17.7% | 4.4% | 61 | 尚无授权文本 |
| CALM CAL-MAINE FOODS INC | 2026-05-30 | 3/3 | $2.91B | $316.68M | $328.53M | 23.1% | 12.0% | 85 | 尚无授权文本 |
| CNM Core & Main, Inc. | 2026-05-03 | 3/3 | $1.91B | $108M | — | 27.2% | 9.3% | 74 | 尚无授权文本 |
| WSM WILLIAMS SONOMA INC | 2026-05-03 | 3/3 | $1.81B | $231.36M | $98.64M | 43.9% | 16.2% | 64 | 尚无授权文本 |
| M Macy's, Inc. | 2026-05-02 | 3/3 | $4.68B | $63M | $204M | 38.9% | 2.4% | 103 | 尚无授权文本 |
| MRVL Marvell Technology, Inc. | 2026-05-02 | 3/3 | $2.42B | $34.5M | $483.1M | 52.1% | 14.0% | 102 | 尚无授权文本 |
| SPWH SPORTSMAN'S WAREHOUSE HOLDINGS, INC. | 2026-05-02 | 3/3 | $256.08M | -$21.85M | -$59.61M | 29.6% | -7.1% | 79 | 尚无授权文本 |
| CRMT AMERICAS CARMART INC | 2026-04-30 | 3/3 | $1.03B | -$139.11M | $63.15M | 35.4% | — | 100 | 尚无授权文本 |
| FMAC Future Money Acquisition Corp | 2026-04-30 | 3/3 | — | $290,108 | — | — | — | 4 | 尚无授权文本 |
| FMACU Future Money Acquisition Corp | 2026-04-30 | 3/3 | — | $290,108 | — | — | — | 4 | 尚无授权文本 |
| MAMA Mama's Creations, Inc. | 2026-04-30 | 3/3 | $52.77M | $2.06M | $4.83M | 23.6% | 5.0% | 69 | 尚无授权文本 |
| MAYS MAYS J W INC | 2026-04-30 | 3/3 | $5.31M | -$216,863 | -$1.51M | — | -6.1% | 65 | 尚无授权文本 |
| MWYN Marwynn Holdings, Inc. | 2026-04-30 | 3/3 | $4.24M | -$3.92M | — | 15.3% | -77.3% | 20 | 尚无授权文本 |
| OOMA OOMA INC | 2026-04-30 | 3/3 | — | $2.58M | $4.93M | — | — | 64 | 尚无授权文本 |
| PMCB PharmaCyte Biotech, Inc. | 2026-04-30 | 3/3 | $0 | -$19.42M | — | — | — | 70 | 尚无授权文本 |
| PPIH Perma-Pipe International Holdings, Inc. | 2026-04-30 | 3/3 | — | $1.8M | $4.86M | — | — | 79 | 尚无授权文本 |
| TITN Titan Machinery Inc. | 2026-04-30 | 3/3 | $522.38M | -$12.62M | — | 17.1% | -1.1% | 65 | 尚无授权文本 |
| WMT Walmart Inc. | 2026-04-30 | 3/3 | $175.68B | $5.33B | -$1.95B | 24.3% | 4.3% | 57 | 尚无授权文本 |
| AMAT APPLIED MATERIALS INC /DE | 2026-04-26 | 3/3 | $7.91B | $2.81B | $1.25B | 49.9% | 31.9% | 81 | 尚无授权文本 |
| VLGEA VILLAGE SUPER MARKET INC | 2026-04-25 | 3/3 | $572.59M | $8.96M | $44.78M | 28.1% | 1.5% | 55 | 尚无授权文本 |
| ARMK Aramark | 2026-04-03 | 3/3 | — | $101.95M | — | — | — | 89 | 尚无授权文本 |
| MTRN MATERION Corp | 2026-04-03 | 3/3 | $549.82M | $19.37M | -$19.6M | 14.9% | 5.1% | 72 | 尚无授权文本 |
| MTSI MACOM Technology Solutions Holdings, Inc. | 2026-04-03 | 3/3 | $288.96M | $46.33M | $95.46M | 56.9% | 17.6% | 69 | 尚无授权文本 |
| VREX Varex Imaging Corp | 2026-04-03 | 3/3 | $216M | -$8.1M | -$34.5M | 33.6% | 6.7% | 70 | 尚无授权文本 |
| AACI Armada Acquisition Corp. III | 2026-03-31 | 3/3 | — | $423,410 | — | — | — | 5 | 尚无授权文本 |
| AAMI Acadian Asset Management Inc. | 2026-03-31 | 3/3 | $167M | $24.3M | — | — | 25.1% | 67 | 尚无授权文本 |
| ABOS Acumen Pharmaceuticals, Inc. | 2026-03-31 | 3/3 | — | -$20.74M | — | — | — | 72 | 尚无授权文本 |
| ABUS Arbutus Biopharma Corp | 2026-03-31 | 3/3 | $179.13M | $169.7M | — | — | 94.3% | 139 | 尚无授权文本 |
| ABVC ABVC BIOPHARMA, INC. | 2026-03-31 | 3/3 | — | -$1.56M | — | — | — | 99 | 尚无授权文本 |
| ABX Abacus Global Management, Inc. | 2026-03-31 | 3/3 | $59.39M | $7.27M | $91.55M | 89.4% | 30.9% | 114 | 尚无授权文本 |
| ABXL Abacus Global Management, Inc. | 2026-03-31 | 3/3 | $59.39M | $7.27M | $91.55M | 89.4% | 30.9% | 114 | 尚无授权文本 |
| ACAD ACADIA PHARMACEUTICALS INC | 2026-03-31 | 3/3 | $268.06M | $3.64M | $28.77M | 90.8% | -1.7% | 83 | 尚无授权文本 |
| ACXP Acurx Pharmaceuticals, Inc. | 2026-03-31 | 3/3 | — | -$1.68M | — | — | — | 56 | 尚无授权文本 |
| ADAM ADAMAS TRUST, INC. | 2026-03-31 | 3/3 | — | $48.6M | — | — | — | 100 | 尚无授权文本 |
| ADAMG ADAMAS TRUST, INC. | 2026-03-31 | 3/3 | — | $48.6M | — | — | — | 100 | 尚无授权文本 |
| ADAMH ADAMAS TRUST, INC. | 2026-03-31 | 3/3 | — | $48.6M | — | — | — | 100 | 尚无授权文本 |
| ADAMI ADAMAS TRUST, INC. | 2026-03-31 | 3/3 | — | $48.6M | — | — | — | 100 | 尚无授权文本 |
| ADAML ADAMAS TRUST, INC. | 2026-03-31 | 3/3 | — | $48.6M | — | — | — | 100 | 尚无授权文本 |
| ADAMM ADAMAS TRUST, INC. | 2026-03-31 | 3/3 | — | $48.6M | — | — | — | 100 | 尚无授权文本 |
| ADAMN ADAMAS TRUST, INC. | 2026-03-31 | 3/3 | — | $48.6M | — | — | — | 100 | 尚无授权文本 |
| ADAMO ADAMAS TRUST, INC. | 2026-03-31 | 3/3 | — | $48.6M | — | — | — | 100 | 尚无授权文本 |
| ADAMZ ADAMAS TRUST, INC. | 2026-03-31 | 3/3 | — | $48.6M | — | — | — | 100 | 尚无授权文本 |
| ADIL ADIAL PHARMACEUTICALS, INC. | 2026-03-31 | 3/3 | — | -$2.02M | — | — | — | 145 | 尚无授权文本 |
| ADMA ADMA BIOLOGICS, INC. | 2026-03-31 | 3/3 | $114.49M | $45.33M | $55.71M | 70.5% | 50.9% | 127 | 尚无授权文本 |
| ADP AUTOMATIC DATA PROCESSING INC | 2026-03-31 | 3/3 | $5.94B | $1.36B | — | 48.3% | — | 78 | 尚无授权文本 |
| AEON AEON Biopharma, Inc. | 2026-03-31 | 3/3 | — | -$11.79M | — | — | — | 104 | 尚无授权文本 |
| AKAM AKAMAI TECHNOLOGIES INC | 2026-03-31 | 3/3 | — | $106.32M | $210.82M | — | — | 87 | 尚无授权文本 |
| ALB ALBEMARLE CORP | 2026-03-31 | 3/3 | $1.43B | $319.09M | $247.57M | 35.1% | 16.3% | 95 | 尚无授权文本 |
| ALMR Alamar Biosciences, Inc. | 2026-03-31 | 3/3 | $26.04M | -$21.33M | -$20.95M | 55.5% | -47.4% | 4 | 尚无授权文本 |
| ALMU Aeluma, Inc. | 2026-03-31 | 3/3 | $1.22M | -$1.8M | -$2.08M | 31.6% | -273.9% | 65 | 尚无授权文本 |
| AMAL Amalgamated Financial Corp. | 2026-03-31 | 3/3 | — | $25.22M | $50.7M | — | — | 107 | 尚无授权文本 |
| AMAN Amanat Acquisition Corp. | 2026-03-31 | 2/3 | — | -$59,901 | — | — | — | 3 | 尚无授权文本 |
| AMG AFFILIATED MANAGERS GROUP, INC. | 2026-03-31 | 3/3 | $544.9M | $110.4M | $295.5M | — | — | 83 | 尚无授权文本 |
| AMLX Amylyx Pharmaceuticals, Inc. | 2026-03-31 | 3/3 | — | -$41.28M | — | — | — | 68 | 尚无授权文本 |
| AMPH Amphastar Pharmaceuticals, Inc. | 2026-03-31 | 3/3 | $171.17M | $6.42M | $38.33M | 41.1% | 8.0% | 81 | 尚无授权文本 |
| AMRX Amneal Pharmaceuticals, Inc. | 2026-03-31 | 3/3 | $722.52M | $62.26M | -$34.92M | 44.3% | 19.6% | 86 | 尚无授权文本 |
| AMSS AMASS BRANDS | 2026-03-31 | 3/3 | $4.15M | -$3.04M | — | 25.9% | -60.8% | 9 | 尚无授权文本 |
| AMT AMERICAN TOWER CORP /MA/ | 2026-03-31 | 3/3 | $216.1M | $878.5M | $951.1M | — | 573.4% | 174 | 尚无授权文本 |
| AMZE AMAZE HOLDINGS, INC. | 2026-03-31 | 3/3 | $469,053 | -$5.61M | — | 92.4% | -1130.4% | 98 | 尚无授权文本 |
| AMZN AMAZON COM INC | 2026-03-31 | 3/3 | $181.52B | $30.26B | — | 51.8% | 13.1% | 86 | 尚无授权文本 |
| ANIP ANI PHARMACEUTICALS INC | 2026-03-31 | 3/3 | $237.46M | $29.49M | $52.3M | — | 16.4% | 115 | 尚无授权文本 |
| APAM Artisan Partners Asset Management Inc. | 2026-03-31 | 3/3 | $303.01M | $58.04M | $181.24M | — | 31.1% | 135 | 尚无授权文本 |
| APO Apollo Global Management, Inc. | 2026-03-31 | 3/3 | $5.06B | -$1.91B | — | — | — | 114 | 尚无授权文本 |
| APOS Apollo Global Management, Inc. | 2026-03-31 | 3/3 | $5.06B | -$1.91B | — | — | — | 114 | 尚无授权文本 |
| APUS Apimeds Pharmaceuticals US, Inc. | 2026-03-31 | 3/3 | — | -$35.06M | -$2.08M | — | — | 24 | 尚无授权文本 |
| ARES Ares Management Corp | 2026-03-31 | 3/3 | $1.4B | $142.59M | — | — | — | 96 | 尚无授权文本 |
| ARMP Armata Pharmaceuticals, Inc. | 2026-03-31 | 3/3 | — | -$115.35M | -$5.85M | — | — | 97 | 尚无授权文本 |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | 2026-03-31 | 3/3 | $73.74M | -$132.73M | $93.21M | — | -191.6% | 86 | 尚无授权文本 |
| ASBP Aspire Biopharma Holdings, Inc. | 2026-03-31 | 3/3 | $28,353 | -$3.22M | — | 20.3% | -5806.0% | 71 | 尚无授权文本 |
| ATNM Actinium Pharmaceuticals, Inc. | 2026-03-31 | 3/3 | — | -$5.52M | -$5.87M | — | — | 46 | 尚无授权文本 |
| ATYR aTYR PHARMA INC | 2026-03-31 | 3/3 | — | -$10.79M | -$12.66M | — | — | 82 | 尚无授权文本 |
| AUPH Aurinia Pharmaceuticals Inc. | 2026-03-31 | 3/3 | $77.71M | $34.36M | — | 91.6% | 53.3% | 91 | 尚无授权文本 |
| AVBP ArriVent BioPharma, Inc. | 2026-03-31 | 3/3 | — | -$43.32M | — | — | — | 36 | 尚无授权文本 |
| AVIR Atea Pharmaceuticals, Inc. | 2026-03-31 | 3/3 | — | -$45.44M | — | — | — | 63 | 尚无授权文本 |
| AVLN Avalyn Pharma Inc. | 2026-03-31 | 3/3 | — | -$26.87M | -$30.21M | — | — | 5 | 尚无授权文本 |
| AWRE AWARE INC /MA/ | 2026-03-31 | 3/3 | — | -$3.46M | -$2.68M | — | — | 80 | 尚无授权文本 |
| AYTU AYTU BIOPHARMA, INC | 2026-03-31 | 3/3 | $12.41M | -$5.62M | -$1.14M | 61.2% | -32.7% | 132 | 尚无授权文本 |
| BACC Blue Acquisition Corp/Cayman | 2026-03-31 | 3/3 | — | $1.11M | — | — | — | 14 | 尚无授权文本 |
| BACCU Blue Acquisition Corp/Cayman | 2026-03-31 | 3/3 | — | $1.11M | — | — | — | 14 | 尚无授权文本 |
| BAM Brookfield Asset Management Ltd. | 2026-03-31 | 3/3 | $990M | $586M | — | — | — | 129 | 尚无授权文本 |
| BBIO BridgeBio Pharma, Inc. | 2026-03-31 | 3/3 | $194.52M | -$166.56M | -$197.35M | 94.9% | -54.5% | 109 | 尚无授权文本 |
| BCRX BIOCRYST PHARMACEUTICALS INC | 2026-03-31 | 3/3 | — | -$721.81M | — | — | — | 132 | 尚无授权文本 |
| BHR Braemar Hotels & Resorts Inc. | 2026-03-31 | 3/3 | $208.98M | $17.7M | — | — | 19.0% | 261 | 尚无授权文本 |
| BIRD Smartbird, Inc. | 2026-03-31 | 3/3 | — | -$20.72M | -$12.14M | — | — | 67 | 尚无授权文本 |
| BMRC Bank of Marin Bancorp | 2026-03-31 | 3/3 | — | $8.51M | $921,000 | — | — | 164 | 尚无授权文本 |
| BMRN BIOMARIN PHARMACEUTICAL INC | 2026-03-31 | 3/3 | $766.21M | $105.53M | $199.73M | 74.6% | 16.9% | 91 | 尚无授权文本 |
| BNTC Benitec Biopharma Inc. | 2026-03-31 | 3/3 | $0 | -$11.94M | -$11.61M | — | — | 97 | 尚无授权文本 |
| BOC BOSTON OMAHA Corp | 2026-03-31 | 3/3 | $28.25M | -$2.15M | -$2.62M | 61.9% | -7.7% | 109 | 尚无授权文本 |
| BWMN Bowman Consulting Group Ltd. | 2026-03-31 | 3/3 | $126.48M | -$3.7M | $9.65M | 52.1% | 0.1% | 75 | 尚无授权文本 |
| CART Maplebear Inc. | 2026-03-31 | 3/3 | $1.02B | $144M | $252M | 72.4% | 17.9% | 35 | 尚无授权文本 |
| CASS CASS INFORMATION SYSTEMS INC | 2026-03-31 | 3/3 | $26.53M | $8.83M | $12.65M | — | — | 67 | 尚无授权文本 |
| CBOE Cboe Global Markets, Inc. | 2026-03-31 | 3/3 | — | $385.7M | $1.94B | — | — | 91 | 尚无授权文本 |
| CNK Cinemark Holdings, Inc. | 2026-03-31 | 3/3 | $643.1M | -$6.4M | — | — | — | 96 | 尚无授权文本 |
| CNSP CNS Pharmaceuticals, Inc. | 2026-03-31 | 3/3 | — | -$4.94M | -$4.65M | — | — | 108 | 尚无授权文本 |
| CNTB Connect Biopharma Holdings Ltd | 2026-03-31 | 3/3 | $169,000 | -$19.4M | -$16.01M | — | -11601.8% | 75 | 尚无授权文本 |
| COAG Hemab Therapeutics Holdings, Inc. | 2026-03-31 | 3/3 | — | -$22.69M | -$21.7M | — | — | 4 | 尚无授权文本 |
| COCP Cocrystal Pharma, Inc. | 2026-03-31 | 3/3 | $225,000 | -$2.3M | — | — | -1047.1% | 118 | 尚无授权文本 |
| COLA Columbus Acquisition Corp/Cayman Islands | 2026-03-31 | 3/3 | — | $61,472 | — | — | — | 22 | 尚无授权文本 |
| COLL COLLEGIUM PHARMACEUTICAL, INC | 2026-03-31 | 3/3 | $193.52M | $14.5M | $56.84M | 60.6% | 16.0% | 94 | 尚无授权文本 |
| CPHI CHINA PHARMA HOLDINGS, INC. | 2026-03-31 | 3/3 | $983,536 | -$1.14M | — | 29.0% | -113.6% | 54 | 尚无授权文本 |
| CPIX CUMBERLAND PHARMACEUTICALS INC | 2026-03-31 | 3/3 | $9.13M | -$3.29M | $387,025 | 78.8% | -34.3% | 98 | 尚无授权文本 |
| CRBP Corbus Pharmaceuticals Holdings, Inc. | 2026-03-31 | 3/3 | — | -$22.97M | -$25.58M | — | — | 118 | 尚无授权文本 |
| CRNX Crinetics Pharmaceuticals, Inc. | 2026-03-31 | 3/3 | $10.73M | -$127.85M | -$125.52M | 98.1% | -1307.8% | 122 | 尚无授权文本 |
| CRVS Corvus Pharmaceuticals, Inc. | 2026-03-31 | 3/3 | — | -$13.69M | -$10.47M | — | — | 87 | 尚无授权文本 |
| CSPI CSP INC /MA/ | 2026-03-31 | 3/3 | $16.01M | $264,000 | -$3.53M | 27.9% | -5.3% | 61 | 尚无授权文本 |
| CTXR Citius Pharmaceuticals, Inc. | 2026-03-31 | 3/3 | $1.67M | -$28.11M | — | 80.3% | -1931.0% | 137 | 尚无授权文本 |
| CUBE CubeSmart | 2026-03-31 | 3/3 | $281.93M | $82.75M | — | 68.1% | — | 110 | 尚无授权文本 |
| CUE Cue Biopharma, Inc. | 2026-03-31 | 3/3 | $5.69M | -$5.18M | -$11.06M | — | -94.1% | 76 | 尚无授权文本 |
| CURX Curanex Pharmaceuticals Inc | 2026-03-31 | 3/3 | — | -$3.15M | — | — | — | 14 | 尚无授权文本 |
| CVR CHICAGO RIVET & MACHINE CO | 2026-03-31 | 3/3 | $6.85M | -$362,015 | — | 14.0% | -5.6% | 43 | 尚无授权文本 |
| CWK Cushman & Wakefield Ltd. | 2026-03-31 | 3/3 | $2.54B | -$12.6M | -$255.7M | — | 2.3% | 108 | 尚无授权文本 |
| DMAA Drugs Made In America Acquisition Corp. | 2026-03-31 | 3/3 | — | $1.97M | — | — | — | 19 | 尚无授权文本 |
| DMAAU Drugs Made In America Acquisition Corp. | 2026-03-31 | 3/3 | — | $1.97M | — | — | — | 19 | 尚无授权文本 |
| DMAC DiaMedica Therapeutics Inc. | 2026-03-31 | 3/3 | — | -$10.04M | -$9.09M | — | — | 84 | 尚无授权文本 |
| DMII Drugs Made In America Acquisition II Corp. | 2026-03-31 | 3/3 | — | $4.34M | — | — | — | 11 | 尚无授权文本 |
| DMIIU Drugs Made In America Acquisition II Corp. | 2026-03-31 | 3/3 | — | $4.34M | — | — | — | 11 | 尚无授权文本 |
| DOUG Douglas Elliman Inc. | 2026-03-31 | 3/3 | $214.33M | -$16.28M | -$19.6M | — | -8.2% | 67 | 尚无授权文本 |
| DRDB Roman DBDR Acquisition Corp. II | 2026-03-31 | 3/3 | — | -$235,067 | — | — | — | 18 | 尚无授权文本 |
| DRDBU Roman DBDR Acquisition Corp. II | 2026-03-31 | 3/3 | — | -$235,067 | — | — | — | 18 | 尚无授权文本 |
| DRMA Dermata Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$1.85M | — | — | — | 94 | 尚无授权文本 |
| ELAN Elanco Animal Health Inc | 2026-03-31 | 3/3 | $1.37B | $57M | -$38M | 57.3% | — | 103 | 尚无授权文本 |
| ELDN Eledon Pharmaceuticals, Inc. | 2026-03-31 | 3/3 | — | -$39.03M | — | — | — | 84 | 尚无授权文本 |
| ELOX Eloxx Pharmaceuticals, Inc. | 2026-03-31 | 3/3 | — | -$3.75M | — | — | — | 81 | 尚无授权文本 |
| EMAT Evolution Metals & Technologies Corp. | 2026-03-31 | 3/3 | $1.88M | -$440.31M | -$5.59M | 23.7% | -833.2% | 87 | 尚无授权文本 |
| EMN EASTMAN CHEMICAL CO | 2026-03-31 | 3/3 | $2.18B | $107M | -$240M | 19.8% | — | 84 | 尚无授权文本 |
| ENTA ENANTA PHARMACEUTICALS INC | 2026-03-31 | 3/3 | $17.16M | -$13.09M | -$19.01M | — | -69.1% | 76 | 尚无授权文本 |
| ESLA Estrella Immunopharma, Inc. | 2026-03-31 | 3/3 | — | -$2.29M | — | — | — | 77 | 尚无授权文本 |
| ETON Eton Pharmaceuticals, Inc. | 2026-03-31 | 3/3 | $24.27M | $1.55M | $7.33M | 60.7% | 9.9% | 138 | 尚无授权文本 |
| FEAM 5E Advanced Materials, Inc. | 2026-03-31 | 3/3 | — | -$12.13M | -$20.35M | — | — | 84 | 尚无授权文本 |
| FEMY FEMASYS INC | 2026-03-31 | 3/3 | $424,889 | $846,100 | -$4.22M | 62.7% | -994.0% | 116 | 尚无授权文本 |
| FENC FENNEC PHARMACEUTICALS INC. | 2026-03-31 | 3/3 | $15.11M | $201,000 | — | — | -0.8% | 80 | 尚无授权文本 |
| FIG Figma, Inc. | 2026-03-31 | 3/3 | $333.44M | -$142.4M | $89.5M | 79.4% | -41.2% | 10 | 尚无授权文本 |
| FIS Fidelity National Information Services, Inc. | 2026-03-31 | 3/3 | $3.3B | $2.37B | — | 33.6% | 12.8% | 114 | 尚无授权文本 |
| FRMM FORUM MARKETS Inc | 2026-03-31 | 3/3 | $2.86M | -$76.26M | -$37.26M | — | -162.0% | 209 | 尚无授权文本 |
| FSP FRANKLIN STREET PROPERTIES CORP /MA/ | 2026-03-31 | 3/3 | $26.23M | -$9.53M | -$7.85M | 60.8% | — | 76 | 尚无授权文本 |
| FUSE Fusemachines Inc. | 2026-03-31 | 3/3 | $1.88M | -$872,000 | -$2.24M | 50.5% | -161.5% | 17 | 尚无授权文本 |
| GABC GERMAN AMERICAN BANCORP, INC. | 2026-03-31 | 3/3 | $122.93M | $33.15M | $35.98M | — | — | 107 | 尚无授权文本 |
| GETY Getty Images Holdings, Inc. | 2026-03-31 | 3/3 | $226.57M | -$4.43M | $23.97M | 70.8% | 13.9% | 73 | 尚无授权文本 |
| GRDN Guardian Pharmacy Services, Inc. | 2026-03-31 | 3/3 | $336.6M | $13.3M | — | 22.7% | 5.3% | 29 | 尚无授权文本 |
| GS GOLDMAN SACHS GROUP INC | 2026-03-31 | 3/3 | — | $5.63B | -$32.43B | — | — | 24 | 尚无授权文本 |
| GSBD Goldman Sachs BDC, Inc. | 2026-03-31 | 3/3 | — | -$13.63M | — | — | — | 120 | 尚无授权文本 |
| GTBP GT Biopharma, Inc. | 2026-03-31 | 3/3 | — | -$2.83M | — | — | — | 90 | 尚无授权文本 |
| HCMA HCM III ACQUISITION CORP. | 2026-03-31 | 3/3 | — | $1.72M | — | — | — | 7 | 尚无授权文本 |
| HCMAU HCM III ACQUISITION CORP. | 2026-03-31 | 3/3 | — | $1.72M | — | — | — | 7 | 尚无授权文本 |
| HMN HORACE MANN EDUCATORS CORP /DE/ | 2026-03-31 | 3/3 | $429.3M | $41.2M | — | — | — | 79 | 尚无授权文本 |
| HUM HUMANA INC | 2026-03-31 | 3/3 | $39.65B | $1.19B | $1.13B | — | 4.4% | 132 | 尚无授权文本 |
| HUMA Humacyte, Inc. | 2026-03-31 | 3/3 | $495,000 | -$17.62M | -$25.28M | -311.7% | -5845.5% | 99 | 尚无授权文本 |
| HUN Huntsman CORP | 2026-03-31 | 3/3 | $1.42B | -$53M | -$91M | 12.9% | -1.1% | 72 | 尚无授权文本 |
| ICMB Investcorp Credit Management BDC, Inc. | 2026-03-31 | 3/3 | — | -$8.63M | — | — | — | 63 | 尚无授权文本 |
| IGC IGC Pharma, Inc. | 2026-03-31 | 3/3 | $317,000 | -$2.4M | -$1.22M | 17.4% | -775.4% | 65 | 尚无授权文本 |
| III Information Services Group Inc. | 2026-03-31 | 3/3 | $61.18M | $2.72M | -$1.51M | 43.1% | 8.2% | 64 | 尚无授权文本 |
| IMA ImageneBio, Inc. | 2026-03-31 | 3/3 | — | -$10.62M | — | — | — | 73 | 尚无授权文本 |
| IMMX Immix Biopharma, Inc. | 2026-03-31 | 3/3 | — | -$10.09M | -$9.86M | — | — | 49 | 尚无授权文本 |
| INDV Indivior Pharmaceuticals, Inc. | 2026-03-31 | 3/3 | $317M | $89M | -$29M | 87.4% | 43.2% | 371 | 尚无授权文本 |
| INM InMed Pharmaceuticals Inc. | 2026-03-31 | 3/3 | — | -$2.97M | — | — | — | 188 | 尚无授权文本 |